Product Information
VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1916 per EA under NDC 00378632577. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 21, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 320 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378632577
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA078020FDA Approved
9/21/2012
TE Code
AB
On Market Since
9/21/2012
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 56.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1916 per EA |
|---|---|
| All-time high | $0.6097 (Nov 11, 2020) |
| All-time low | $0.1905 (Nov 20, 2024) |
| 52-week high | $0.2220 |
| 52-week low | $0.1916 |
| Median price | $0.3080 |
| Average price | $0.3224 |
| Largest weekly change | +33.7% (Oct 21, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
valsartan and hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.1916 per EA (NDC 00378632577), effective Sep 30, 2026.
How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB changed over time?
Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has declined 56.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
Since Nov 28, 2013, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has ranged from a low of $0.1905 (Nov 20, 2024) to a high of $0.6097 (Nov 11, 2020), with a median of $0.3080 per EA.
Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB (NDC 00378632577) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.